General End Period Cash Flow from 2010 to 2024

GICRE Stock   397.65  1.75  0.44%   
General Insuranceof End Period Cash Flow yearly trend continues to be very stable with very little volatility. End Period Cash Flow is likely to drop to about 169.9 B. During the period from 2010 to 2024, General Insuranceof End Period Cash Flow quarterly data regression pattern had sample variance of 3532673512.9 T and median of  129,331,368,000. View All Fundamentals
 
End Period Cash Flow  
First Reported
2010-12-31
Previous Quarter
248.6 B
Current Value
169.9 B
Quarterly Volatility
59.4 B
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check General Insuranceof financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among General Insuranceof's main balance sheet or income statement drivers, such as Depreciation And Amortization of 124 M, Interest Expense of 7 M or Selling General Administrative of 147.3 M, as well as many indicators such as . General financial statements analysis is a perfect complement when working with General Insuranceof Valuation or Volatility modules.
  
This module can also supplement various General Insuranceof Technical models . Check out the analysis of General Insuranceof Correlation against competitors.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in General Stock

General Insuranceof financial ratios help investors to determine whether General Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in General with respect to the benefits of owning General Insuranceof security.